Hims & Hers Health, Inc.
For the period ended Mar 31, 2026. Filed May 11, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 11, 2026
HIMS$19.13-16.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity
Condensed Consolidated Statements of Stockholders' Equity (Unaudited)
(In Thousands, Except Share Data)
| Common Stock · AdditionalPaid-InCapital · Accumulated Other Comprehensive (Loss) Income · AccumulatedDeficit · TotalStockholders' Equity | ||||||
|---|---|---|---|---|---|---|
| Shares · Amount | ||||||
| Balance as of December 31, 2025 | 227,245,521 | $23 | $652,383 | $2,294 | $(113,772) | $540,928 |
| Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes | 2,226,629 | — | — | — | — | — |
| Payments for taxes related to net share settlement of equity awards | — | — | (39,206) | — | — | (39,206) |
| Exercise of vested stock options | 1,085,188 | — | 5,008 | — | — | 5,008 |
| Common stock issued for asset acquisition indemnification holdback | 146,402 | — | — | — | — | — |
| Stock-based compensation | — | — | 38,251 | — | — | 38,251 |
| Other comprehensive loss | — | — | — | (6,699) | — | (6,699) |
| Net loss | — | — | — | — | (92,115) | (92,115) |
| Balance as of March 31, 2026 | 230,703,740 | $23 | $656,436 | $(4,405) | $(205,887) | $446,167 |
| Common Stock · AdditionalPaid-InCapital · AccumulatedOtherComprehensiveLoss · AccumulatedDeficit · TotalStockholders' Equity | ||||||
|---|---|---|---|---|---|---|
| Shares · Amount | ||||||
| Balance as of December 31, 2024 | 220,837,209 | $22 | $719,155 | $(324) | $(242,137) | $476,716 |
| Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes | 1,179,653 | — | — | — | — | — |
| Payments for taxes related to net share settlement of equity awards | — | — | (25,711) | — | — | (25,711) |
| Exercise of vested stock options | 1,274,229 | — | 3,928 | — | — | 3,928 |
| Issuance of common stock for acquisition of assets | 292,806 | — | 12,760 | — | — | 12,760 |
| Common stock to be issued for asset acquisition indemnification holdback | — | — | 6,380 | — | — | 6,380 |
| Stock-based compensation | — | — | 25,543 | — | — | 25,543 |
| Other comprehensive income | — | — | — | 160 | — | 160 |
| Net income | — | — | — | — | 49,485 | 49,485 |
| Balance as of March 31, 2025 | 223,583,897 | $22 | $742,055 | $(164) | $(192,652) | $549,261 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.